title: Infections in relapsed or refractory acute myeloid leukemia patients given clofarabine+cytarabine.
authors.forename: Randall W
authors.initials: RW
authors.lastname: Knoebel
authors.forename: Amy
authors.initials: A
authors.lastname: McQuary
authors.forename: Pamela
authors.initials: P
authors.lastname: Becker
authors.forename: Paul
authors.initials: P
authors.lastname: Hendrie
authors.forename: Stephen
authors.initials: S
authors.lastname: Petersdorf
authors.forename: Frederick R
authors.initials: FR
authors.lastname: Appelbaum
authors.forename: Eli
authors.initials: E
authors.lastname: Estey
mesh_terms: D000227:Adenine Nucleotides / Q000008:administration & dosage*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001087:Arabinonucleosides / Q000008:administration & dosage*; D000077866:Clofarabine; D003561:Cytarabine / Q000008:administration & dosage*; D019008:Drug Resistance, Neoplasm / Q000502:physiology; D006801:Humans; D007239:Infections / Q000150:complications* / Q000175:diagnosis; D015470:Leukemia, Myeloid, Acute / Q000150:complications* / Q000188:drug therapy* / Q000473:pathology; D012008:Recurrence; D017211:Treatment Failure
chemical_list: D000227:Adenine Nucleotides; D001087:Arabinonucleosides; D003561:Cytarabine; D000077866:Clofarabine